Medication Adherence Improvement Support App For Engagement - Blood Pressure

Completed · Not applicable

Conditions studied: Hypertension

In brief

The purpose of this study is to evaluate the impact of the Medisafe smartphone application on blood pressure control and self-reported medication adherence for patients with uncontrolled blood pressure.

Key facts

Study ID

NCT02727543

Run by

Brigham and Women's Hospital

People needed

413

Starts

2016-04-01

Expected to finish

2017-01-01

Last updated by the study team

2017-01-18

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Between 18 - 75 years of age
• Self-reported systolic blood pressure greater than or equal to 140 mmHg
• Self-reported use of 1-3 of the following anti-hypertensive medications (thiazide, CCB, beta-blocker, ACE-I, ARB)
• Systolic blood pressure greater than or equal to140 mmHg (+/- diastolic blood pressure greater than or equal to 90 mmHg), but blood pressure less than or equal to 180/120 mmHg confirmed by home BP-cuff

You may not qualify if…

• Current use of a smartphone medication adherence application
• No ownership of a smartphone with iOS or Android operating system
• Currently taking more than 3 anti-hypertensive medications (thiazide, CCB, beta-blocker, ACE-I, ARB) by self report
• Currently undergoing dialysis
• Currently receiving chemotherapy or radiation
• Does not understand English

Where it is running

• Evidation Health — Menlo Park, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.